New drug shows promise for rare heart condition in chinese patients
NCT ID NCT06194825
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 28 times
Summary
This study tests a drug called eplontersen in Chinese adults with a heart condition caused by a faulty protein (transthyretin amyloid cardiomyopathy). The goal is to see if the drug safely lowers that protein and improves heart health. About 64 participants will receive either eplontersen or a placebo for 24 weeks, then everyone gets the drug for another 80 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSTHYRETIN AMYLOID CARDIOMYOPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Beijing, 100029, China
-
Research Site
Beijing, 100034, China
-
Research Site
Beijing, 100037, China
-
Research Site
Beijing, 100191, China
-
Research Site
Beijing, 100730, China
-
Research Site
Changsha, 410008, China
-
Research Site
Changsha, 410013, China
-
Research Site
Changsha, 430033, China
-
Research Site
Chengdu, 610041, China
-
Research Site
Chengdu, 610072, China
-
Research Site
Chongqing, 400010, China
-
Research Site
Chongqing, 400042, China
-
Research Site
Guangzhou, 510062, China
-
Research Site
Guangzhou, 510100, China
-
Research Site
Hangzhou, 310003, China
-
Research Site
Hangzhou, 310014, China
-
Research Site
Hangzhou, 310052, China
-
Research Site
Ha’erbin, 150001, China
-
Research Site
Jinan, 250001, China
-
Research Site
Nanchang, 330006, China
-
Research Site
Shanghai, 200032, China
-
Research Site
Suzhou, 215006, China
-
Research Site
Taiyuan, 030001, China
-
Research Site
Wuhan, 430030, China
-
Research Site
Wuhan, 430060, China
-
Research Site
Xi'an, 710061, China
Conditions
Explore the condition pages connected to this study.